腫瘍アブレーションの世界市場:技術別(ラジオ波、マイクロ波、冷凍アブレーション、その他)、治療方法別(手術アブレーション、腹腔鏡アブレーション、経皮アブレーション)、用途別(肝臓がん、肺がん、腎臓がん、その他)

◆英語タイトル:Global Tumor Ablation Market Size study, by Technology (Radiofrequency, Microwave, Cryoablation, Others), by Mode of Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), by Application (Liver Cancer, Lung Cancer, Kidney Cancer, Others) and Regional Forecasts 2019-2026
◆商品コード:BZW20FB167
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年1月21日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥668,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、腫瘍アブレーションの世界市場について調べ、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、技術別(ラジオ波、マイクロ波、冷凍アブレーション、その他)分析、治療方法別(手術アブレーション、腹腔鏡アブレーション、経皮アブレーション)分析、用途別(肝臓がん、肺がん、腎臓がん、その他)分析、地域別分析、競争状況などで構成されています。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・腫瘍アブレーションの世界市場:技術別(ラジオ波、マイクロ波、冷凍アブレーション、その他)
・腫瘍アブレーションの世界市場:治療方法別(手術アブレーション、腹腔鏡アブレーション、経皮アブレーション)
・腫瘍アブレーションの世界市場:用途別(肝臓がん、肺がん、腎臓がん、その他)
・腫瘍アブレーションの世界市場:地域別
・競争状況
【レポートの概要】

Global Tumor Ablation Market is valued approximately at USD 407.42 million in 2018 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2019-2026. Tumor ablation is a minimally invasive technique which is usually used in the treatment of tumors of the bone, kidneys, liver and lungs. At the time of tumor ablation, thermal energy is used to cool or heat tissue to cytotoxic levels (below −40°C or over 60°C). It is a vital option for the people who have failed chemotherapy or radiotherapy or are not surgical candidates. Ablation is also being observed as a potential first-line treatment in many patients with small hepatocellular carcinomas or benign tumors in the liver. Increasing incidences of cancer, growing geriatric population, technological advancements in ablation devices and surging government programs to reduce the cancer incidence are the few factors responsible for high CAGR of the market over the forecast period. For instance, in 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million deaths due to cancer worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Moreover, growing awareness about ablation procedures over conventional therapeutic and surgical procedures is another the major factor which creates lucrative growth opportunities to the growth of market in the upcoming years. However, cost containment measures taken by various governments and long approval time for the product launch are the few factors anticipated to restrain the growth of global Tumor Ablation market during the forecast period.

The regional analysis of global Tumor Ablation Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing acceptance of tumor ablation products due to rising prevalence of cancer, surging inclination of patients towards minimally invasive procedures and increasing government funding for cancer research in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as improving healthcare infrastructure, increasing number of cancer patients and growing government assistance programs to reduce cancer incidence would fuel-up the adoption of Tumor Ablation in the Asia-Pacific region.

Major market player included in this report are:
Medtronic, PLC.
Angiodynamics, Inc.
Healthtronics, Inc.
Galil Medical, Inc.
Boston Scientific Corporation
Neuwave Medical, Inc.
Edap Tms S.A.
Mermaid Medical A/S
Sonacare Medical, LLC
Misonix, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Radiofrequency
Microwave
Cryoablation
Others

By Mode of Treatment:
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation

By Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Tumor Ablation Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Tumor Ablation Market, by Technology, 2017-2026 (USD Million)
1.2.2. Tumor Ablation Market, by Mode of Treatment, 2017-2026 (USD Million)
1.2.3. Tumor Ablation Market, by Application, 2017-2026 (USD Million)
1.2.4. Tumor Ablation Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tumor Ablation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tumor Ablation Market Dynamics
3.1. Tumor Ablation Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Tumor Ablation Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Tumor Ablation Market, by Technology
5.1. Market Snapshot
5.2. Global Tumor Ablation Market by Technology, Performance – Potential Analysis
5.3. Global Tumor Ablation Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
5.4. Tumor Ablation Market, Sub Segment Analysis
5.4.1. Radiofrequency
5.4.2. Microwave
5.4.3. Cryoablation
5.4.4. Others
Chapter 6. Global Tumor Ablation Market, by Mode of Treatment
6.1. Market Snapshot
6.2. Global Tumor Ablation Market by Mode of Treatment, Performance – Potential Analysis
6.3. Global Tumor Ablation Market Estimates & Forecasts by Mode of Treatment, 2016-2026 (USD Million)
6.4. Tumor Ablation Market, Sub Segment Analysis
6.4.1. Surgical Ablation
6.4.2. Laparoscopic Ablation
6.4.3. Percutaneous Ablation
Chapter 7. Global Tumor Ablation Market, by Application
7.1. Market Snapshot
7.2. Global Tumor Ablation Market by Application, Performance – Potential Analysis
7.3. Global Tumor Ablation Market Estimates & Forecasts by Application, 2016-2026 (USD Million)
7.4. Tumor Ablation Market, Sub Segment Analysis
7.4.1. Liver Cancer
7.4.2. Lung Cancer
7.4.3. Kidney Cancer
7.4.4. Others
Chapter 8. Global Tumor Ablation Market, Regional Analysis
8.1. Tumor Ablation Market, Regional Market Snapshot
8.2. North America Tumor Ablation Market
8.2.1. U.S. Tumor Ablation Market
8.2.1.1. Technology breakdown estimates & forecasts, 2016-2026
8.2.1.2. Mode of Treatment breakdown estimates & forecasts, 2016-2026
8.2.1.3. Application breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Tumor Ablation Market
8.3. Europe Tumor Ablation Market Snapshot
8.3.1. U.K. Tumor Ablation Market
8.3.2. Rest of Europe Tumor Ablation Market
8.4. Asia-Pacific Tumor Ablation Market Snapshot
8.4.1. China Tumor Ablation Market
8.4.2. India Tumor Ablation Market
8.4.3. Japan Tumor Ablation Market
8.4.4. Rest of Asia Pacific Tumor Ablation Market
8.5. Latin America Tumor Ablation Market Snapshot
8.5.1. Brazil Tumor Ablation Market
8.5.2. Mexico Tumor Ablation Market
8.6. Rest of The World Tumor Ablation Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Medtronic, PLC.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject To Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Angiodynamics, Inc.
9.2.3. Healthtronics, Inc.
9.2.4. Galil Medical, Inc.
9.2.5. Boston Scientific Corporation
9.2.6. Neuwave Medical, Inc.
9.2.7. Edap Tms S.A.
9.2.8. Mermaid Medical A/S
9.2.9. Sonacare Medical, LLC
9.2.10. Misonix, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL TUMOR ABLATION MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TUMOR ABLATION MARKET
TABLE 3. GLOBAL TUMOR ABLATION MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
TABLE 8. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY MODE OF TREATMENT 2016-2026 (USD MILLION)
TABLE 9. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 23. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 26. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 29. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 32. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 35. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 38. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 44. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 59. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 60. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 61. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 62. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 63. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 64. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 65. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 66. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 67. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 68. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 69. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 70. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 71. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 72. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 73. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 74. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 75. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 76. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 77. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 78. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 79. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 80. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 81. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 82. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 83. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 84. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 85. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 86. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 87. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 88. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 89. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 90. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 91. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 92. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 93. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 94. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 95. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 96. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 97. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 98. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 99. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 100. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 101. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 102. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[腫瘍アブレーションの世界市場:技術別(ラジオ波、マイクロ波、冷凍アブレーション、その他)、治療方法別(手術アブレーション、腹腔鏡アブレーション、経皮アブレーション)、用途別(肝臓がん、肺がん、腎臓がん、その他)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆